BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 7516348)

  • 1. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
    Weissman A; Loumaye E; Shoham Z
    Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration.
    Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Spettoli D; Taraborrelli S; Ciampaglia W
    Hum Reprod; 2002 Aug; 17(8):2009-15. PubMed ID: 12151429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
    Carone D; Caropreso C; Vitti A; Chiappetta R
    J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
    J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: a nonrandomized controlled pilot study.
    Awwad JT; Farra C; Mitri F; Abdallah MA; Jaoudeh MA; Ghazeeri G
    Reprod Biomed Online; 2013 Jan; 26(1):88-92. PubMed ID: 23177418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
    Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
    Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
    Hohmann FP; Laven JS; de Jong FH; Eijkemans MJ; Fauser BC
    Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
    Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
    Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism.
    Balasch J; Fábregues F
    Reprod Biomed Online; 2003 Jun; 6(4):427-31. PubMed ID: 12831587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone.
    Adonakis G; Deshpande N; Yates RW; Fleming R
    Fertil Steril; 1998 Mar; 69(3):450-3. PubMed ID: 9531875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin requirements of the developing follicle.
    Thompson KA; LaPolt PS; River J; Henderson G; Dahl KD; Meldrum DR
    Fertil Steril; 1995 Feb; 63(2):273-6. PubMed ID: 7843430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of follicle maturation and ovulation by gonadotropin administration in women with beta-thalassemia.
    Danesi L; Scacchi M; Miragoli AM; Pincelli AI; Dubini A; Maiolo AT; Cavagnini F; Polli EE
    Eur J Endocrinol; 1994 Dec; 131(6):602-6. PubMed ID: 7804443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.